Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of High Dose U-500 Regular Insulin in T2DM
NCT02148250Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by University of Minnesota. Started Jul 2015; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02148250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148250.